Strados Labs is at the forefront of respiratory health technology with its innovative RESP® Biosensor, the first FDA-cleared wearable stethoscope designed for continuous monitoring of lung sounds, including coughs and wheezes. This device allows for real-time data collection on lung health from the hospital to home, providing valuable insights for better patient care and research. Strados Labs aims to enhance the management of conditions such as asthma, chronic cough, and COPD through this advanced technology that captures detailed acoustic data while ensuring privacy with end-to-end encryption.

Founded with a mission to improve respiratory monitoring, Strados Labs has achieved significant milestones including multiple FDA clearances and a CE mark. The RESP Biosensor is not only clinically validated but also designed for everyday use, making it comfortable and unobtrusive for patients. With an impressive global reach across four continents and multiple languages, Strados continues to pioneer solutions that help both healthcare providers and patients make informed decisions about lung health.